PURPOSE: The purpose is to address the problem in magnetic resonance imaging (MRI) of contrast agent dilution. PROCEDURES: In situ magnetic labeling of cells and MRI were used to assess distribution and growth of human hepatic stem cells (hHpSCs) transplanted into severe combined immunodeficiency (SCID)/non-obese diabetic (NOD) mice. It was done with commercially available magnetic microbeads coupled to an antibody to a surface antigen, epithelial cell adhesion molecule (EpCAM), uniquely expressed in the liver by hepatic progenitors. RESULTS: We validated the microbead connection to cells and related MRI data to optical microscopy observations in order to develop a means to quantitatively estimate cell numbers in the aggregates detected. Cell counts of hHpSCs at different times post-transplantation revealed quantifiable evidence of cell engraftment and expansion. CONCLUSIONS: This magnetic labeling methodology can be used with any antibody coupled to a magnetic particle to target any surface antigen that distinguishes transplanted cells from host cells, thus facilitating studies that define methods and strategies for clinical cell therapy programs.
PURPOSE: The purpose is to address the problem in magnetic resonance imaging (MRI) of contrast agent dilution. PROCEDURES: In situ magnetic labeling of cells and MRI were used to assess distribution and growth of human hepatic stem cells (hHpSCs) transplanted into severe combined immunodeficiency (SCID)/non-obese diabetic (NOD) mice. It was done with commercially available magnetic microbeads coupled to an antibody to a surface antigen, epithelial cell adhesion molecule (EpCAM), uniquely expressed in the liver by hepatic progenitors. RESULTS: We validated the microbead connection to cells and related MRI data to optical microscopy observations in order to develop a means to quantitatively estimate cell numbers in the aggregates detected. Cell counts of hHpSCs at different times post-transplantation revealed quantifiable evidence of cell engraftment and expansion. CONCLUSIONS: This magnetic labeling methodology can be used with any antibody coupled to a magnetic particle to target any surface antigen that distinguishes transplanted cells from host cells, thus facilitating studies that define methods and strategies for clinical cell therapy programs.
Authors: R Susick; N Moss; H Kubota; E Lecluyse; G Hamilton; T Luntz; J Ludlow; J Fair; D Gerber; K Bergstrand; J White; A Bruce; O Drury; S Gupta; L M Reid Journal: Ann N Y Acad Sci Date: 2001-11 Impact factor: 5.691
Authors: Glenn A Walter; Kevin S Cahill; Johnny Huard; Huisheng Feng; T Douglas; H Lee Sweeney; Jeff W M Bulte Journal: Magn Reson Med Date: 2004-02 Impact factor: 4.668
Authors: Jonathan M Hill; Alexander J Dick; Venkatesh K Raman; Richard B Thompson; Zu-Xi Yu; K Allison Hinds; Breno S S Pessanha; Michael A Guttman; Timothy R Varney; Bradley J Martin; Cynthia E Dunbar; Elliot R McVeigh; Robert J Lederman Journal: Circulation Date: 2003-08-11 Impact factor: 29.690
Authors: Michal Gropp; Pavel Itsykson; Orna Singer; Tamir Ben-Hur; Etti Reinhartz; Eithan Galun; Benjamin E Reubinoff Journal: Mol Ther Date: 2003-02 Impact factor: 11.454
Authors: Ling-Jia Wang; Yong Ming Chen; David George; Francois Smets; Etienne M Sokal; Eric G Bremer; Humberto E Soriano Journal: Liver Transpl Date: 2002-09 Impact factor: 5.799
Authors: Laurent Dollé; Neil D Theise; Eva Schmelzer; Luke Boulter; Olivier Gires; Leo A van Grunsven Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-12-04 Impact factor: 4.052
Authors: Elizabeth Bull; Seyed Yazdan Madani; Roosey Sheth; Amelia Seifalian; Mark Green; Alexander M Seifalian Journal: Int J Nanomedicine Date: 2014-03-31